newsfilter
← Latest News
PR Newswire·

Provention Bio to Report Third Quarter 2022 Financial Results on November 3, 2022

RED BANK, N.J., Oct. 13, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its